Cafepharma Today

June 17 2025 - Lilly to acquire Verve in $1B bet on gene editing for heart disease
Lilly to acquire Verve in $1B bet on gene editing for heart disease
Mineralys' hypertension drug continues winning streak, lowering blood pressure in phase 2
Fired ACIP members: RFK Jr. has ‘critically weakened’ U.S. vaccine program
Caris swells its planned IPO, seeking $5.7bn valuation
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis drug Afinitor® approved by FDA as first medication for children and adults with a benign brain tumor associated with tuberous sclerosis
PharmPro
Saturday, October 30, 2010 - 1:00pm
tags:
Novartis, Afinitor, tuberous sclerosis, brain tumors
7 Pharma Stocks Near 52-Week Highs
Motley Fool
Saturday, October 30, 2010 - 12:43pm
tags:
JNJ, Novartis, Merck, Abbott Laboratories, AstraZeneca, Novo Nordisk
Vertex, Merck Drugs Help More with Faster Cure for Hepatitis C in Studies
Bloomberg
Saturday, October 30, 2010 - 12:41pm
tags:
Vertex Pharmaceuticals, Merck, hepatitis C, Telaprevir, Roche, Pegasys
Merck's Investigational Medicine Boceprevir Achieved Significantly Higher SVR Rates In Treatment-Failure and Treatment-Naïve Adult Patients with Chronic Hepatitis C Genotype 1 Compared to Control
Yahoo/BusinessWire
Saturday, October 30, 2010 - 12:39pm
tags:
Merck, hepatitis C, Boceprevir
Cost Cuts Help Merck to Avert Revenue Losses
NY Times
Saturday, October 30, 2010 - 12:37pm
tags:
Merck, Vioxx
Merck Books $950 Million Vioxx Charge .
WSJ
Saturday, October 30, 2010 - 12:36pm
tags:
Merck, legal, Vioxx
Earnings Preview: Pfizer to tout new drugs, deals
Yahoo/AP
Saturday, October 30, 2010 - 12:35pm
tags:
Pfizer, earnings, tasocitinib, pain management, stroke, Laboratorio Teuto Brasileiro S.A
Pfizer Sues Apotex, Mylan to Block Generic Viagra
Bloomberg
Saturday, October 30, 2010 - 12:31pm
tags:
Pfizer, Apotex, Mylan, Viagra
Glaxo recalls 1 lot of Emo-Cort lotion in Canada
Yahoo/AP
Saturday, October 30, 2010 - 12:30pm
tags:
GSK, Emo-Cort, eczema, dermatitis
J&J probes Crucell's manufacturing mishap
Yahoo/AP
Saturday, October 30, 2010 - 12:28pm
tags:
JNJ, Crucell
Is Provenge The Most Important Medicine In Biotech?
Forbes
Saturday, October 30, 2010 - 12:27pm
tags:
Provenge, Dendreon, prostate cancer
Idera Pharmaceuticals Presents Phase 1 Data on IMO-2125 Demonstrating Induction of Broad Antiviral Immune Response in Null-Responder HCV Patients
Yahoo/BusinessWire
Saturday, October 30, 2010 - 12:23pm
tags:
Idera Pharmaceuticals, IMO-2125, hepatitis C
Viread® for Hepatitis B Maintains Antiviral Suppression with No Development of Resistance Through Four Years of Treatment
Yahoo/BusinessWire
Saturday, October 30, 2010 - 12:22pm
tags:
Viread, Gilead Sciences, hepatitis B
ANA598 Data Presented at AASLD Highlight Positive Clinical Profile of DAA Entering Phase IIb
Yahoo/PR NewsWire
Saturday, October 30, 2010 - 12:16pm
tags:
hepatitis C, Anadys, ANA598
Diet Drug Optimism Lifts Shares of Vivus
NY Times
Saturday, October 30, 2010 - 12:14pm
tags:
Vivus, Qnexa, obesity
Bristol-Myers, Gilead Seek AIDS Cocktail Success in Hepatitis C
Bloomberg
Saturday, October 30, 2010 - 11:53am
tags:
Bristol-Myers Squibb, Gilead Sciences, HIV, hepatitis C
Questcor Pharmaceuticals Shares Popped: What You Need to Know
Motley Fool
Saturday, October 30, 2010 - 11:51am
tags:
Questcor Pharmaceuticals
Is Now The Time To Buy Pharmaceuticals?
Investopedia
Saturday, October 30, 2010 - 11:49am
tags:
Eli Lilly, Biogen Idec, Gilead Sciences
Biotech Calendar: Key Dates for November
TheStreet.com
Friday, October 29, 2010 - 12:11pm
tags:
biotech, Merck, Gilead Sciences, Indenix, Pharmasset, Bristol-Myers Squibb, Dendreon, Cadence Pharmaceuticals, Vical, MELA Sciences, Human Genome Sciences, Amgen
Shire Profit Rises on Vyvanse Sales, Genzyme Delays
Bloomberg
Friday, October 29, 2010 - 12:05pm
tags:
Shire, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

AI Effects on Drug Patents
In the Pipeline
Mirror Morphine
In the Pipeline
Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.